PHARMACEUTICAL SOLUTIONS:
FROM RAW MATERIAL
TO FINISHED PRODUCT
Portocanna connects the medicinal cannabis value chain, from raw material to distribution. We enhance cultivators’ output by transforming it into EU-GMP pharmaceutical-grade products, ensuring batch release for destination markets.
We support innovation by providing the infrastructure and expertise required to convert raw materials into viable and scalable products. In the final stage, we ensure the availability of a diverse portfolio of cannabis plant-based substances and preparations through logistical efficiency, guaranteeing patient access to quality products.
PRODUCT
+ Diversity
+ Delivery Methods
+ IP Access
RISK MITIGATION
+ Quality Assurance
+ Procurement Network
+ Handling
ECONOMICALLY
+ SCALE
– RISK
FROM HARVEST TO BATCH RELEASE
We maximise the value of your harvest through technical batch qualification and regulatory support. Ensure EU-GMP compliance and gain direct access to European distribution channels for pharmacy sales.
Portocanna connects cultivation to distribution, ensuring the commercial stability your business requires. We reduce time-to-market and maximise the profitability of each production cycle.
FROM HARVEST TO BATCH RELEASE
We maximise the value of your harvest through technical batch qualification and regulatory support. Ensure EU-GMP compliance and gain direct access to European distribution channels for pharmacy sales.
Portocanna connects cultivation to distribution, ensuring the commercial stability your business requires. We reduce time-to-market and maximise the profitability of each production cycle.
ASSETS
Focusing on the processing link of the value chain, we invested in a 3,000sqm EU-GMP certified facility in Portugal comprised of:
• Fully equipped post-harvest processing room
• Dedicated quality control lab
• Certified extraction facility
• Large-scale packaging lines
• Large warehousing capacity
CAPABILITIES
With the diverse, highly specialized experiences of our team members and the symbiotic partnerships we have developed, we are building:
• Efficient operational processes
• Vast IP of strains & growers
• Strict pharma-grade SOPs
• Proprietary extraction methodologies
• Unique formulations
Co-financed by:
Lorem